5-aminosalicylic acid and olsalazine inhibit tumor growth in a rodent model of colorectal cancer

被引:51
作者
Brown, WA [1 ]
Farmer, KC [1 ]
Skinner, SA [1 ]
Malcontenti-Wilson, C [1 ]
Misajon, A [1 ]
O'Brien, PE [1 ]
机构
[1] Monash Univ, Alfred Hosp, Dept Surg, Prahran, Vic 3181, Australia
关键词
chemoprevention; colorectal cancer; 5-aminosalicylic acid; olsalazine; apoptosis; bromdeoxyuridine;
D O I
10.1023/A:1005517112039
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The ability of 5-aminosalicylic acid and olsalazine to inhibit colonic aberrant crypts and tumors was investigated in 1,2-dimethylhydrazine-treated rats. The effect of these drugs on the rates of tumor apoptosis and proliferation was studied as potential mechanisms for their action. 5-Aminosalicylic acid reduced the number of aberrant crypt foci by over one third, while olsalazine had no effect on this parameter. However, both agents effectively reduced tumor number and load, increased the rare of tumor apoptosis, and reduced the rate of tumor cell proliferation. In conclusion, 5-aminosalicylic acid and olsalazine are both ultimately effective chemopreventive agents in this model; however, only 5-aminosalicylic acid inhibited the formation of aberrant crypt foci. The inhibitory effect of these agents in tumors is related to the inhibition of proliferation and the induction of apoptosis.
引用
收藏
页码:1578 / 1584
页数:7
相关论文
共 40 条
[1]   THE TUMOR-SUPPRESSOR GENE-PRODUCT APC BLOCKS CELL-CYCLE PROGRESSION FROM G(0)/G(1) TO S-PHASE [J].
BAEG, GH ;
MATSUMINE, A ;
KURODA, T ;
BHATTACHARJEE, RN ;
MIYASHIRO, I ;
TOYOSHIMA, K ;
AKIYAMA, T .
EMBO JOURNAL, 1995, 14 (22) :5618-5625
[2]   Chemoprevention of colorectal cancer - The mechanism of NSAID effect is multifactorial. [J].
Brown, W ;
Skinner, S ;
Vogiagis, D ;
Malcontenti-Wilson, C ;
deJong, T ;
Van Driel, I ;
Farmer, K ;
O'Brien, P .
GASTROENTEROLOGY, 1998, 114 (04) :A571-A571
[3]  
BROWN W, 1998, J GASTROEN HEPATOL, V13, pA128
[4]   Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis [J].
Chan, TA ;
Morin, PJ ;
Vogelstein, B ;
Kinzler, KW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) :681-686
[5]   Sulindac and indomethacin inhibit formation of aberrant crypt foci in the colons of dimethyl hydrazine treated rats [J].
Charalambous, D ;
Farmer, C ;
OBrien, PE .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1996, 11 (01) :88-92
[6]  
Charalambous D, 1998, J GASTROEN HEPATOL, V13, P1195
[7]   Inhibition of colon cancer precursors in the rat by sulindac sulphone is not dependent on inhibition of prostaglandin synthesis [J].
Charalambous, D ;
OBrien, PE .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1996, 11 (04) :307-310
[8]  
Chiu CH, 1997, CANCER RES, V57, P4267
[9]   RISK FOR SERIOUS GASTROINTESTINAL COMPLICATIONS RELATED TO USE OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS - A METAANALYSIS [J].
GABRIEL, SE ;
JAAKKIMAINEN, L ;
BOMBARDIER, C .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (10) :787-796
[10]   SCAVENGER EFFECT OF SULFASALAZINE, 5-AMINOSALICYLIC ACID, AND OLSALAZINE ON SUPEROXIDE RADICAL GENERATION [J].
GIONCHETTI, P ;
GUARNIERI, C ;
CAMPIERI, M ;
BELLUZZI, A ;
BRIGNOLA, C ;
IANNONE, P ;
MIGLIOLI, M ;
BARBARA, L .
DIGESTIVE DISEASES AND SCIENCES, 1991, 36 (02) :174-178